December 4, 2020
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
| Re: | Cyclo Therapeutics, Inc. |
Registration Statement on Form S-1, as amended (File No. 333-249136) |
Ladies and Gentlemen:
As the underwriter of the proposed offering of Cyclo Therapeutics, Inc. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness for 4:30 p.m., Eastern Time, on December 7, 2020, or as soon thereafter as is practicable.
The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
| Very truly yours, | |
|
| |
| Maxim Group LLC | |
|
| |
| By: | /s/ Clifford A. Teller |
|
| Name: Clifford A. Teller Managing Director |